| Mild | Moderate | Severe* | Total | p-Value |
---|---|---|---|---|---|
Outpatient visits | Â | Â | Â | Â | Â |
 Rate (%) | 3,798 (83.9%) | 2,002(91.0%) | 234(44.6%) | 6,034(83.2%) | 0.000 |
 Frequency (SD, all patients ) | 2.2 (3.2) | 2.8 (3.7) | 1.3 (2.4) | 2.3 (3.3) | 0.0001 |
 Frequency (SD, patients who had the visits) | 2.6(3.3) | 3.1(3.8) | 2.8(3.0) | 2.8(3.5) | 0.0001 |
 Duration (day) | 1.0(0.0) | 1.0(0.0) | 1.0(0.0) | 1.0(0.0) | 1.0000 |
Emergency room visits | Â | Â | Â | Â | Â |
 Rate (%) | 493 (10.9%) | 146 (6.6%) | 39 (7.4%) | 678 (9.4%) | 0.000 |
 Frequency (SD, all patients) | 0.2 (0.7) | 0.1(0.9) | 0.1(0.3) | 0.2 (0.7) | 0.0123 |
 Frequency (SD, patients who had the visits) | 1.6 (1.3) | 1.9 (3.1) | 1.1 (0.3) | 1.6 (1.8) | 0.1626 |
 Duration (day) | 1.1(0.8) | 1.1 (1.1) | 2.9 (3.7) | 1.2 (1.2) | 0.0296 |
Hospital admission | Â | Â | Â | Â | Â |
 Rate (%) | 487 (10.8%) | 172 (7.8%) | 299 (57.0%) | 958 (13.2%) | 0.000 |
 Frequency (SD, all patients) | 0.1 (0.4) | 0.1 (0.3) | 0.6 (0.7) | 0.1 (0.4) | 0.0001 |
 Frequency (SD, patients who had the admission) | 1.1 (0.4) | 1.1 (0.4) | 1.1 (0.6) | 1.1 (0.5) | 0.8623 |
 Duration (day) | 9.9 (4.7) | 10.1 (6.7) | 11.5 (5.9) | 10.4 (5.5) | 0.0001 |
Medication | Â | Â | Â | Â | Â |
 Utilization rate of OCS (%) | 117 (2.6%) | 33 (1.5%) | 110 (21.0%) | 260 (3.6%) | 0.0000 |
 Utilization rate of ICS + LABA (%) | 278 (6.1%) | 1,902 (86.5%) | 436 (83.1%) | 2,616 (36.1%) | 0.0000 |
Diagnosis | Â | Â | Â | Â | Â |
 Detection rate of total IgE (%) | 49 (1.1%) | 22 (1.0%) | 43 (8.2%) | 114 (1.6%) | 0.000 |